Also from this source

You just read:

Xlumena Announces Initial Commercial Use of its First-in-Class AXIOS Stent and Delivery System for Treatment of Pancreatic Pseudocysts and Fluid Collections

News provided by

Xlumena, Inc.

Jan 09, 2014, 10:16 EST